With only $41 million in cash, Tvardi Therapeutics may need to raise additional funds within a one-year period. Click here to ...
Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback